Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. Show more
BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire MINNEAPOLIS, Dec. 20, 2024 MINNEAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH...
BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT PR Newswire MINNEAPOLIS, Dec. 19, 2024 MINNEAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Bio-Techne...
ScaleReady awards a G-Rex® Grant to Moonlight Bio PR Newswire ST. PAUL, Minn., Dec. 18, 2024 ST. PAUL, Minn., Dec. 18, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf...
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY PR Newswire MINNEAPOLIS, Dec. 12, 2024 MINNEAPOLIS, Dec. 12, 2024 /PRNewswire/...
BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY PR Newswire MINNEAPOLIS, Dec. 10, 2024 Company will showcase new assay at the upcoming San Antonio Breast Cancer Symposium MINNEAPOLIS, Dec. 10...
BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE PR Newswire MINNEAPOLIS, Nov. 27, 2024 MINNEAPOLIS, Nov. 27, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today...
Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne PR Newswire WEST SACRAMENTO, Calif., Nov. 25, 2024 WEST SACRAMENTO, Calif., Nov...
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES PR Newswire MINNEAPOLIS, Nov. 20, 2024 MINNEAPOLIS, Nov. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH...
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO PR Newswire MINNEAPOLIS, Nov. 14, 2024 Customers will present data from their use of...
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS PR Newswire MINNEAPOLIS, Nov. 11, 2024 R&D Systems Hematology Controls and Calibrators has completed the Class...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.8 | 1.11888111888 | 71.5 | 74.27 | 69.48 | 1047148 | 72.64911167 | CS |
| 4 | -3.03 | -4.02230187176 | 75.33 | 78.42 | 69.48 | 749192 | 74.66161113 | CS |
| 12 | -4.64 | -6.03067325188 | 76.94 | 80.8 | 65.61 | 919662 | 72.81378184 | CS |
| 26 | -0.55 | -0.754975978037 | 72.85 | 83.62 | 65.61 | 913776 | 74.11254926 | CS |
| 52 | -5.36 | -6.9018799897 | 77.66 | 85.57 | 61.16 | 981222 | 73.2752576 | CS |
| 156 | -51.7025 | -41.6947238967 | 124.0025 | 130.74 | 51.79 | 770289 | 76.08298719 | CS |
| 260 | 16.9725 | 30.6764267317 | 55.3275 | 135.9625 | 38.7925 | 548773 | 78.04011177 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
